comparemela.com

Latest Breaking News On - European company contact - Page 1 : comparemela.com

CytoSorbents Announces Pivotal STAR-T Trial Reaches First Milestone With 40 Patients Enrolled

/PRNewswire/ CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac.

United statesEfthymiosn deliargyrisJosephine krausEric kimMarcus schultMichaelj mackKathleen blochMaterial commandEuropean company contactCardiovascular serviceEuropean unionBaylor plano research centerUs armyBlood instituteNational heartCytosorbents corporation

CytoSorbents Reports Third Quarter 2022 Financial and Operational Results

/PRNewswire/ CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac.

New jerseyUnited statesState of new jerseyJosephine krausAstra zenecaPhillip chanMarcus schultKathleen blochJanssen bayerUs centers of diseaseDepartment of defenseEuropean company contactMaterial commandUs national institutes of healthTurkish ministry of healthEuropean association for cardio

CytoSorbents Reports Third Quarter 2022 Financial and Operational Results

/PRNewswire/ CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac.

New jerseyUnited statesState of new jerseyJosephine krausAstra zenecaPhillip chanMarcus schultKathleen blochJanssen bayerUs centers of diseaseDepartment of defenseEuropean company contactMaterial commandUs national institutes of healthTurkish ministry of healthEuropean association for cardio

Turkish Ministry of Health Grants National Reimbursement to CytoSorb®

Press release content from PR Newswire. The AP news staff was not involved in its creation.

United statesSouheil el hakimChristian steinerJosephine krausEric kimAmy vogelMarcus schultOffice of turkeyMaterial commandEuropean company contactTurkish ministry of healthFor solutionsEuropean unionUs armyBlood instituteNational heart

Israeli Ministry of Health Approves National Coverage for CytoSorb®

/PRNewswire/ CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac.

United statesChristian steinerJosephine krausEric kimAmy vogelMarcus schultIsrael heart societyMaterial commandEuropean company contactMinistry of healthHospital technologies committee of the israeli moEuropean unionUs armyBlood instituteNational heartCytosorbents corporation

vimarsana © 2020. All Rights Reserved.